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Rare localization of low-grade ﬁbromyxoid
sarcoma to the nail region
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SIR, Low-grade fibromyxoid sarcoma (LGFMS) is a rare soft
tissue tumour. Its incidence is not known and it has not been
universally established as a clinicopathological entity. It was
originally described by Evans in 19871 as ‘a metastasizing soft
tissue tumour with a deceptively benign histological appear-
ance’. Successive other descriptions2–5 have appeared in the
literature, to support the existence of this tumour as a distinct
entity with emphasis on its indolent but malignant behaviour.
Several cases showed metastatic spread to the lung. Neverthe-
less, the disease runs a protracted course in most patients.
Most were still alive 10 years after excision of the primary
lesion, and recurrences can be treated successfully by re-
excision, chemotherapy and radiotherapy.
LGFMS typically arises in the deep soft tissue of young and
middle-aged adults, and the most frequent sites reported in
the literature are the trunk, neck and roots of the limbs. Other
rare localizations are the retroperitoneum, mediastinum, falci-
form ligament and small bowel mesentery.2,3,6,7,8 LGFMS has
rarely been described in the hands and, to our knowledge, all
such cases included aspects of ‘hyalinizing spindle cell tumour
with giant rosettes’.6 To our knowledge, no cases of LGFMS
have been described in the nail region.
We report two cases of digital soft tumours, located in the
nail region, which we encountered between 2000 and 2003.
Our two cases did not show any aspect of ‘giant rosettes’ and
satisfied all Evans’ histological criteria for LGFMS: the presence
of spindle-shaped and stellate cells with relatively hyperchro-
matic but uniform nuclei, a predominantly whorled arrange-
ment of these cells, the presence of alternating areas with a
fibrous or a myxoid stroma (occasionally with an abrupt
transition from one to the other) and a bland nodular pattern
of growth (Fig. 1).
The immunohistochemical results were in agreement with
those reported in the literature.1–6 There was strong positivity
for vimentin and CD99 and negativity for S100 and epithelial
membrane antigen (EMA). Furthermore, our two cases were
negative for actin, desmin, pankeratin and CD34. Although
the full significance of the immunohistochemical profile is
unclear, we know that CD99 has been demonstrated in sub-
populations of fibroblasts.9 We hypothesize that these findings
in LGFMS are compatible with a CD34– ⁄CD99 + subpopula-
tion of fibroblasts.
Regarding malignant soft tissue tumours, the main differen-
tial diagnosis of LGFMS includes low-grade myxofibrosarcoma,
myxoid malignant peripheral nerve sheath tumour and
acral myxoinflammatory fibroblastic sarcoma.10,11 We wish to
emphasize that LGFMS, with its deceptively bland appearance,
may be mistaken for a benign lesion. Thus the differential
diagnosis with benign soft tissue tumours, e.g. myxoid neuro-
fibroma, desmoid fibromatosis, superficial angiomyxoma and
superficial acral fibromyxoma (SAFM)10,11 is very important.
In relation to the particular localization, we consider that
the most important differential diagnosis of our cases of
LGFMS is with SAFM,6 a distinctive soft tissue tumour that has
a predilection for the hands and feet of middle-aged individu-
als. It is typically located in the dermis, sometimes involving
the subcutis, and in a few instances extending to the fascia or
to the periosteal surface of the bone. It is characterized by
spindle-shaped and stellate fibroblast-like cells with random,
loose storiform, and fascicular growth patterns. The lesional
cells are embedded in myxoid, myxocollagenous or collagen-
ous matrix, often with mildly to moderately accentuated vas-
culature (most notable in the highly myxoid examples). Mast
cells are easily identified. SAFM is positive for CD34, EMA and
CD99. Our two cases showed many similarities with SAFM
because the tumours were from acral sites (nail region of the
fingers) and, like SAFM, they had variable amounts of myxoid
matrix, spindle-shaped cells with random and loose storiform
growth patterns, and increased vascularity. In contrast to
SAFM, in our cases the myxoid areas were circumscribed and
delimited by fibrous bundles forming different sized nodules
with an abrupt transition from one type of area to the other.
Moreover, we did not detect the presence of mast cells, either
with toluidine blue stain or with CD117 antibody. Finally,
CD34 and EMA were negative.9
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Fetsch et al.6 found two of 23 cases of SAFM to be negative
for CD34, and a further case to be recurrent. Five cases
showed nuclear atypia and the authors suggested the possibil-
ity that SAFM may progress to a low-grade neoplasm (fibro-
myxoid tumour of low malignant potential). We consider that
SAFM and LGFMS are two different entities, both histologically
and immunohistochemically. Perhaps the two CD34– cases
and ⁄or the recurrent case reported by Fetsch et al. are LGFMS
ab initio. In fact, the picture of the recurrent case shows an
abrupt transition between fibrous and myxoid areas. More-
over, we consider that some ‘cutaneous and subcutaneous
low-grade myxoid neoplasms with recurrent potential’ can
represent cases of LGFMS, when they are negative for CD34
and S100.12,13
Finally, we hypothesize that the superficial localization of
LGFMS, like other soft tissue tumours (i.e. low-grade lipoma-
tous tumours, low-grade myxofibrosarcomas), could be a
good prognostic factor. However, long-term follow-up of a
greater number of cases is required to assess the real beha-
viour of these superficial low-grade fibromyxoid tumours.
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Fig 1. (a) Tumour in papillary dermis, with
a Grenz zone, under the epithelium of the
nail matrix. (b) Myxoid areas circumscribed
and delimited by fibrous bundles forming
nodules with an abrupt transition from one
type of area to the other. (c) Cells in a
whorled and partially storiform pattern of
growth, with a network of curvilinear
and branching capillary-sized vessels.
(d) Extremely hypocellular areas with dense
fibrous background; the swirling pattern is
still discernible. (e) Stellate and spindle-
shaped cells with poorly defined cytoplasm
and small oval nuclei that were bent and
wavy in appearance. (f) Pleomorphism was
very slight and mitoses were very rare, fewer
than 1 per 30 high-power fields (HPF)
(1 HPF ¼ 0Æ159 mm2). (g) Apoptotic cells,
with strongly eosinophilic cytoplasm and
hyperchromic ⁄condensed nuclei, more than
3 per HPF.
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A novel type of human papillomavirus
(HPV 95): comparison with infections of
closely related human papillomavirus types
DOI: 10.1111/j.1365-2133.2005.06825.x
SIR, Infection with certain human papillomavirus (HPV) types
induces warts with specific macroscopic and microscopic fea-
tures.1 Clinical, histological and virological correlations have
been established between myrmecia (deep palmoplantar
warts), granular intracytoplasmic inclusion bodies (Gr-ICBs)
and HPV 1, between pigmented warts, homogeneous (Hg)-
ICBs and the related HPV 4, 60 and 65, and between punctate
warts, filamentous (Fl)-ICBs and HPV 63.
We recently observed a distinct type of Hg-ICB in small
wart-like lesions in a 16-year-old Japanese renal transplant
recipient with a 2-year history of viral warts on her hands and
feet (Fig. 1a). The asymptomatic small warty papules of
normal skin colour shared some resemblance to those of
HPV 2 ⁄27 ⁄57-induced common warts, HPV 4 ⁄60 ⁄65-induced
pigmented warts, or HPV 88-associated small wart-like
lesions.2 Microscopically, the epidermis was acanthotic with
hyperkeratosis and partial hypergranulosis, with basic histolog-
ical features compatible with those of common warts. The
additional histological feature of eosinophilic Hg-ICBs sur-
rounding a vacuolated nucleus in each cell in the granular and
upper spinous cell layers was characteristic for all lesions
examined (Figs 1b,c). These microscopic features of the
Hg-ICBs resembled those of HPV 4 ⁄65-associated Hg-ICBs
(Figs 1d,e) to a certain extent, but were quite distinct from
those of HPV 60-associated Hg-ICBs (Fig. 1f), as well as those
of HPV 1-associated Gr-ICBs, HPV 63-associated Fl-ICBs and
HPV 88-associated fibrillar ICBs. The subsequent comparative
analysis of lesions displaying the different types of Hg-ICB
revealed an abundance of the HPV 95-associated Hg-ICBs in
the upper epidermal cell layers, similar to that seen in
HPV 4 ⁄65-associated lesions, in contrast to a few scattered
cells in the HPV 60-infected lesions. HPV 95-associated Hg-
ICBs shared the feature of eosinophilic bodies with a crescent-
like appearance with HPV 4 ⁄65-associated Hg-ICBs, in contrast
to the round bodies in HPV 60-associated Hg-ICBs. The cres-
cent-like eosinophilic bodies were, however, usually ‘atrophic’
and separated from an extremely vacuolated nucleus in
HPV 4-induced warts, in contrast to that seen in HPV 65 ⁄95-
induced warts where they filled out the entire cytoplasm and
encased the nucleus. Tiny vesicular structures seen within
HPV 4 ⁄65-associated Hg-ICBs were not seen in Hg-ICBs asso-
ciated with HPV 95. Clear distinction between the different
types of Hg-ICB was not always possible, despite the differ-
ences mentioned.
The full-length genome of a novel papillomavirus was
cloned from these lesions and characterized. The DNA
genome of HPV 95 consists of 7337 base pairs (accession
number AJ620210). The genome shows a gene arrangement
characteristic for all HPVs, except for the absence of a distinct
E5 open reading frame between the early and late regions,
similar to other cutaneous HPV types.3 The nucleotide
sequence of the HPV 95 L1 open reading frame shares 80%
homology to HPV 65 L1 and 79% homology to HPV 4 L1,
thereby defining this novel HPV type to species 1 of the
genus Gamma-papillomavirus.3 The percentage homology to
HPV 60 L1 (species 4) is 62% and to HPV 88 L1 (species 5)
is 61%.
The present case is the only patient with HPV 95-associ-
ated inclusion warts studied thus far, suggesting that HPV 95
is an extremely rare HPV type. It seems likely that the condi-
tions accompanying the immunosuppression of this renal
transplant recipient may have contributed to stimulate viral
production of HPV 95, thus leading to wart formation. To
ascertain the true nature of HPV 95 and its associated inclu-
sion warts, we need to perform epidemiological, as well as
further clinicopathological and virological studies on a larger
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